USA Pending Home Sales (MoM) for Nov (2.200)% vs 0.500% Est

USA Pending Home Sales (MoM) for Nov (2.200)% vs 0.500% consensus estimate. The prior reading was 7.500%.

byBill Haddad

December 29, 2021

1 minute read

USA Pending Home Sales (MoM) for Nov (2.200)% vs 0.500% consensus estimate. The prior reading was 7.500%.

‘Despite Presidential Rumors, Ted Cruz Says His Focus On 2024 Is Winning Re-Election To Senate’ – Houston Chronicle

By Happy Mohamed

Today, 3:41 AM

https://www.houstonchronicle.com/politics/texas/article/ted-cruz-says-running-u-s-senate-re-election-17782481.php?utm_source=twitter.com&utm_campaign=sftwitter&utm_medium=referral

SPY

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

By Vandana Singh

Today, 3:41 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

Teledyne FLIR Defense Receives $62M In Orders From U.S. Military For Centaur Unmanned Ground Vehicles

By Benzinga Newsdesk

Today, 3:41 AM

Teledyne FLIR Defense Receives $62 Million in Orders from U.S. Military for Centaur Unmanned Ground Vehicles U.S. Army and Navy commands request nearly 500 additional robots; Latest award raises MTRS Inc. II

TDY

Citigroup Maintains Buy on HubSpot, Raises Price Target to $750

By Benzinga Newsdesk

Today, 3:41 AM

Citigroup analyst Drew Foster maintains HubSpot (NYSE:HUBS) with a Buy and raises the price target from $655 to $750.

HUBS

USA Pending Home Sales (MoM) for Nov (2.200)% vs 0.500% Est

Related Posts

‘Despite Presidential Rumors, Ted Cruz Says His Focus On 2024 Is Winning Re-Election To Senate’ – Houston Chronicle

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

Teledyne FLIR Defense Receives $62M In Orders From U.S. Military For Centaur Unmanned Ground Vehicles

Citigroup Maintains Buy on HubSpot, Raises Price Target to $750